PT90120B - Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica - Google Patents
Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermicaInfo
- Publication number
- PT90120B PT90120B PT90120A PT9012089A PT90120B PT 90120 B PT90120 B PT 90120B PT 90120 A PT90120 A PT 90120A PT 9012089 A PT9012089 A PT 9012089A PT 90120 B PT90120 B PT 90120B
- Authority
- PT
- Portugal
- Prior art keywords
- deprenil
- transdermic
- preparation
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888807504A GB8807504D0 (en) | 1988-03-29 | 1988-03-29 | Improvements in/relating to organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
PT90120A PT90120A (pt) | 1989-11-10 |
PT90120B true PT90120B (pt) | 1994-06-30 |
Family
ID=10634325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT90120A PT90120B (pt) | 1988-03-29 | 1989-03-27 | Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0404807B1 (pt) |
JP (1) | JP2533211B2 (pt) |
KR (1) | KR0136870B1 (pt) |
AU (1) | AU630088B2 (pt) |
CA (1) | CA1336071C (pt) |
DE (1) | DE68907406T2 (pt) |
ES (1) | ES2013129A6 (pt) |
FI (1) | FI895681A0 (pt) |
GB (1) | GB8807504D0 (pt) |
GR (1) | GR1003711B (pt) |
HU (1) | HU207441B (pt) |
IE (1) | IE62955B1 (pt) |
IL (1) | IL89748A (pt) |
MY (1) | MY105121A (pt) |
NZ (1) | NZ228467A (pt) |
PT (1) | PT90120B (pt) |
WO (1) | WO1989009051A1 (pt) |
ZA (1) | ZA892321B (pt) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
HU209605B (en) * | 1991-04-15 | 1994-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of wather-free transdermal preparation |
EP0593807A1 (en) * | 1992-10-22 | 1994-04-27 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation |
HUT63579A (en) * | 1991-12-20 | 1993-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
US5242950A (en) * | 1992-04-23 | 1993-09-07 | Somerset Pharmaceuticals, Inc. | Treatment of macular degeneration |
CA2161004C (en) * | 1993-04-20 | 2004-10-26 | Wilfried Fischer | Active ingredient patch |
ATE199829T1 (de) * | 1994-06-03 | 2001-04-15 | Thejmde Trust | Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon |
HU223475B1 (hu) * | 1994-10-24 | 2004-07-28 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására |
US6348208B1 (en) | 1995-01-13 | 2002-02-19 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline |
US6319954B1 (en) | 1995-01-13 | 2001-11-20 | Somerset Pharmaceuticals, Inc. | S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions |
US6299901B1 (en) | 1995-01-13 | 2001-10-09 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline |
US6033682A (en) * | 1995-01-13 | 2000-03-07 | Somerset Pharmaceuticals, Inc. | S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions |
US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
IL122484A0 (en) | 1995-06-07 | 1998-06-15 | Noven Pharma | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
DE19533089C1 (de) | 1995-09-07 | 1997-05-22 | Hexal Ag | Tacrin-Pflaster |
DE19533772C1 (de) * | 1995-09-12 | 1998-01-02 | Hexal Ag | Tacrin/Selegilin-Pflaster |
IL119417A (en) * | 1996-10-13 | 2003-02-12 | Moshe Kushnir | Pharmaceutical composition for transdermal administration of levodopa for parkinson's disease |
US7150881B2 (en) | 1997-06-26 | 2006-12-19 | Mylan Technologies, Inc. | Adhesive mixture for transdermal delivery of highly plasticizing drugs |
AU750909B2 (en) | 1998-03-16 | 2002-08-01 | Somerset Pharmaceuticals, Inc. | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
DE19814257A1 (de) | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
CA2380391A1 (en) † | 1998-12-07 | 2000-06-15 | J. Miranda | Transdermal patch for delivering volatile liquid drugs |
PT1441708E (pt) | 2001-11-05 | 2009-06-18 | Krele Pharmaceuticals Llc | Composições e métodos para aumentar a observância de terapias utilizando inibidores da aldeído desidrogenase e para tratar alcoolismo |
DE10338174A1 (de) * | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
SG157415A1 (en) | 2004-11-23 | 2009-12-29 | Adamas Pharmaceuticals Inc | Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
CA2604052C (en) | 2005-04-06 | 2014-07-08 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of cns-related conditions |
US7846445B2 (en) | 2005-09-27 | 2010-12-07 | Amunix Operating, Inc. | Methods for production of unstructured recombinant polymers and uses thereof |
US7855279B2 (en) | 2005-09-27 | 2010-12-21 | Amunix Operating, Inc. | Unstructured recombinant polymers and uses thereof |
KR101500022B1 (ko) * | 2007-06-21 | 2015-03-06 | 가부시키가이샤 후지모토 코포레이션 | 경피 또는 경점막 투여용 조성물 |
US8933197B2 (en) | 2007-08-15 | 2015-01-13 | Amunix Operating Inc. | Compositions comprising modified biologically active polypeptides |
WO2010091122A1 (en) | 2009-02-03 | 2010-08-12 | Amunix, Inc. | Extended recombinant polypeptides and compositions comprising same |
EA030619B1 (ru) | 2009-06-08 | 2018-09-28 | Амуникс Оперейтинг Инк. | Гибридный белок, включающий последовательности гормона роста и xten, способ его получения и применения |
AU2010258898B8 (en) | 2009-06-08 | 2015-02-05 | Amunix Operating Inc. | Glucose-regulating polypeptides and methods of making and using same |
US20120263701A1 (en) | 2009-08-24 | 2012-10-18 | Volker Schellenberger | Coagulation factor vii compositions and methods of making and using same |
MX2012006320A (es) | 2009-12-02 | 2013-01-18 | Adamas Pharmaceuticals Inc | Composiciones de amantadina y metodos para su uso. |
EP2552967A4 (en) | 2010-04-02 | 2014-10-08 | Amunix Operating Inc | BINDING FUSION PROTEINS, BINDING FUSION PROTEIN MEDICINAL CONJUGATES, XTEN MEDICAMENT CONJUGATES, AND METHOD FOR THEIR PREPARATION AND USE |
DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
LT2814840T (lt) | 2012-02-15 | 2020-02-25 | Bioverativ Therapeutics Inc. | Faktoriaus viii kompozicijos ir jų gavimo ir naudojimo būdai |
EP2822577B1 (en) | 2012-02-15 | 2019-02-06 | Bioverativ Therapeutics Inc. | Recombinant factor viii proteins |
US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
EP3033097B1 (en) | 2013-08-14 | 2021-03-10 | Bioverativ Therapeutics Inc. | Factor viii-xten fusions and uses thereof |
AU2016301303B2 (en) | 2015-08-03 | 2021-10-07 | Bioverativ Therapeutics Inc. | Factor IX fusion proteins and methods of making and using same |
WO2018071656A1 (en) | 2016-10-14 | 2018-04-19 | Knowles Enterprises Inc. | Formulations for treatment of migraines |
WO2018200885A1 (en) | 2017-04-26 | 2018-11-01 | Neurocentria, Inc. | Magnesium compositions and methods of use |
AU2019270184A1 (en) | 2018-05-18 | 2020-11-26 | Bioverativ Therapeutics Inc. | Methods of treating hemophilia A |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0139127A1 (en) * | 1983-08-22 | 1985-05-02 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Transdermal drug delivery device and its preparation |
IL72684A (en) * | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
EP0241809B1 (de) * | 1986-04-16 | 1990-08-08 | ASTA Pharma Aktiengesellschaft | Synergistische Kombination von Amantadin und Selegilin |
-
1988
- 1988-03-29 GB GB888807504A patent/GB8807504D0/en active Pending
-
1989
- 1989-03-18 DE DE89903719T patent/DE68907406T2/de not_active Revoked
- 1989-03-18 WO PCT/EP1989/000291 patent/WO1989009051A1/en not_active Application Discontinuation
- 1989-03-18 JP JP1503424A patent/JP2533211B2/ja not_active Expired - Lifetime
- 1989-03-18 HU HU892559A patent/HU207441B/hu unknown
- 1989-03-18 AU AU32900/89A patent/AU630088B2/en not_active Expired
- 1989-03-18 EP EP89903719A patent/EP0404807B1/en not_active Revoked
- 1989-03-23 IE IE92189A patent/IE62955B1/en not_active IP Right Cessation
- 1989-03-23 NZ NZ228467A patent/NZ228467A/en unknown
- 1989-03-27 PT PT90120A patent/PT90120B/pt not_active IP Right Cessation
- 1989-03-27 IL IL89748A patent/IL89748A/xx unknown
- 1989-03-27 GR GR890100190A patent/GR1003711B/el not_active IP Right Cessation
- 1989-03-28 MY MYPI89000387A patent/MY105121A/en unknown
- 1989-03-29 ZA ZA892321A patent/ZA892321B/xx unknown
- 1989-03-29 CA CA000595075A patent/CA1336071C/en not_active Expired - Fee Related
- 1989-03-29 ES ES8901101A patent/ES2013129A6/es not_active Expired - Lifetime
- 1989-11-28 FI FI895681A patent/FI895681A0/fi not_active Application Discontinuation
- 1989-11-28 KR KR1019890702205A patent/KR0136870B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH02503677A (ja) | 1990-11-01 |
IL89748A (en) | 1993-07-08 |
GB8807504D0 (en) | 1988-05-05 |
IE890921L (en) | 1989-09-29 |
KR900700089A (ko) | 1990-08-11 |
JP2533211B2 (ja) | 1996-09-11 |
HU207441B (en) | 1993-04-28 |
AU3290089A (en) | 1989-10-16 |
GR890100190A (el) | 1990-01-19 |
PT90120A (pt) | 1989-11-10 |
KR0136870B1 (ko) | 1998-04-25 |
NZ228467A (en) | 1991-12-23 |
DE68907406D1 (de) | 1993-08-05 |
EP0404807A1 (en) | 1991-01-02 |
AU630088B2 (en) | 1992-10-22 |
FI895681A0 (fi) | 1989-11-28 |
WO1989009051A1 (en) | 1989-10-05 |
GR1003711B (el) | 2001-10-25 |
HUT55220A (en) | 1991-05-28 |
MY105121A (en) | 1994-08-30 |
ZA892321B (en) | 1990-12-28 |
DE68907406T2 (de) | 1993-10-14 |
EP0404807B1 (en) | 1993-06-30 |
ES2013129A6 (es) | 1990-04-16 |
CA1336071C (en) | 1995-06-27 |
HU892559D0 (en) | 1990-01-28 |
IE62955B1 (en) | 1995-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT90120A (pt) | Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica | |
PT91731A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas | |
PT83756B (pt) | Processo para a preparacao de composicoes farmaceuticas com libertacao controlada | |
PT83459B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo o ester de 1-acetoxietilo da cefuroxima | |
PT89276A (pt) | Processo para a preparacao de uma formulacao farmaceutica de libertacao prolongada | |
PT83508B (pt) | Processo para a preparacao de composicoes farmaceuticas de accao prolongada | |
PT84785B (pt) | Processo para a preparacao de composicoes farmceuticas que contem omeprazole para administracao por via oral | |
PT88612A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo um agente anti-calculo dental | |
PT84786B (pt) | Processo para a preparacao de composicoes farmaceuticas que contem compostos acidos labeis parea administracao por via oral | |
PT88099A (pt) | Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada | |
PT87703A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo um derivado de 1,4-di-hidropiridina e um intensificador do fluxo transdermico | |
PT87190A (pt) | Processo para a preparacao de composicoes farmaceuticas para a reducao dos efeitos indesejaveis das beta-lactaminas | |
PT84416B (pt) | Processo para a preparacao de formas de dosagem de libertacao controlada para administracao oral contendo polissacaridos de origem natural | |
PT90689A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo ibuprofen em associacao com um piperidinoalcanol | |
PT89094A (pt) | Processo para a preparacao de 1-aril-3-quinolina-e 1-aril-3-isoquinolina-carboxamidas e de composicoes farmaceuticas que as contem | |
PT88225A (pt) | Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas | |
PT87957A (pt) | Processo para a preparacao de uma composicao farmaceutica contendo um analogo da somatostatina | |
PT89497A (pt) | Processo para a preparacao de compostos piperidinilicos 1,4-dissubstituidos e de composicoes farmaceuticas que os contem | |
PT92120A (pt) | Processo para a preparacao de composicoes oftalmologicas contendo ciclosporina | |
PT90888A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas | |
NO173590C (no) | Fremgangsmaate for fremstilling av et stabilt nikorandilholdig farmasoeytisk preparat | |
PT90435A (pt) | Processo aperfeicoado para a preparacao de uma cetimina | |
PT81605B (pt) | Processo para a preparacao de derivados de imidazolilalquil-guanidina e de composicoes farmaceuticas contendo estes compostos | |
PT97550A (pt) | Processo para a preparacao de uma composicao farmaceutica contendo ibuprofeno, e uma prostaglandina | |
BR8904400A (pt) | Processo para a preparacao de uma formulacao pesticida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19931213 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20090327 |